GCWM
TLSI icon

Graham Capital Wealth Management’s TriSalus Life Sciences TLSI Stock Holding History

Graham Capital Wealth Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,893
Closed -$705K – 134
2023
Q1 		$705K Buy
+6,893
New +$69.9K 0.1% 87
2022
Q4 		– Sell
-27,311
Closed -$271K – 66
2022
Q3 		$271K Sell
27,311
-1,200
-4% -$11.9K 0.33% 47
2022
Q2 		$281K Sell
28,511
-2,240
-7% -$22K 0.25% 73
2022
Q1 		$301K Buy
30,751
+8,072
+36% +$79.7K 0.27% 75
2021
Q4 		$226K Buy
+22,679
New +$225K 0.18% 93

Other funds holding TLSI

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Graham Capital Wealth Management's TLSI Position: Q2 2023 in Review

Graham Capital Wealth Management sold out of TriSalus Life Sciences (TLSI) in Q2 2023, closing a stake of 6,893 shares — an estimated $705K sold.

Graham Capital Wealth Management first reported a position in TLSI in Q4 2021 and held it in 5 quarters. The position peaked at $705K in Q1 2023. 6 funds tracked by Wall St. Rank hold TLSI as of Q2 2023.

  • Graham Capital Wealth Management reported no remaining TriSalus Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Graham Capital Wealth Management sold 6,893 TriSalus Life Sciences shares in Q2 2023, an estimated $705K.
  • Graham Capital Wealth Management first reported a position in TriSalus Life Sciences in Q4 2021 and held it in 5 quarters.
  • Graham Capital Wealth Management's TriSalus Life Sciences position peaked at $705K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2023.

Based on Graham Capital Wealth Management's 13F filing for Q2 2023, filed 25 Jul 2023.